Women in Pulmonary: Sex & Gender Differences in Diagnosing and Treating Asthma, COPD, and ILD

Both sex and gender differences are poorly portrayed in many aspects of lung development and disease and terminology often misused. It is evident, however, that female sex and gender play a clear role in many aspects of lung physiology, biology, and pathology. This role may translate into differences in disease susceptibility, presentation, severity and associated outcomes, as well as response to treatment. Pharmacodynamics and drug metabolism may also differ by sex, with recommendations for different dosing regimens of certain drugs in females. Sex and Gender webinarNearly every cell in the human body has a sex and the latter can influence cell function. Hence, the large gap in the understanding of the role of sex in disease presentation, diagnosis, and treatment is surprising. In this webinar, featuring Drs. Sonye Danoff, Dawn DeMeo and Joe Zein and moderators Drs. Ghada Bourjeily and Sharon Elliot, CHEST will address these issues and cover topics on: - Ways to recognize differences between women and men in COPD, asthma, and ILD susceptibility; symptom presentation, morbidity and mortality; and how to apply this to clinical practice -The effects of gender and sex hormones on asthma severity over a lifetime -Gender-based precision care